Therefore, SSTR2 serves as an important marker for differential diagnosis and treatment selection between NETs and NEC.11) In the present case, despite the presence of typical NEC, a diffuse and distinct membrane expression was observed, especially in the postoperative NEC component. The gene discussed is SSTR2; the disease is neuroendocrine carcinoma.